CannBioRx Life Sciences C...
0.01
-0.00 (-2.91%)
At close: Jan 15, 2025, 2:58 PM
0.01
1.05%
After-hours Jan 15, 2025, 02:59 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
PE Ratio -0.08 -0.17 -5.98 -4.06 -0.67 -1.02 89.04
PS Ratio n/a n/a n/a n/a n/a n/a n/a
PB Ratio -12.05 0.57 3.09 1.61 0.44 -1.93 2.20
P/FCF Ratio -0.14 -0.53 -6.27 -12.59 -4.93 -3.75 -22.16
P/OCF Ratio -0.14 -0.53 -6.27 -12.59 -5.15 -3.78 -22.16
OCF/S Ratio n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio -8.25 0.12 0.05 0.12 0.09 n/a n/a
Quick Ratio 0.72 1.69 0.46 0.14 0.05 0.11 2.26
Current Ratio 0.72 1.58 0.57 0.19 0.08 0.11 2.26
Asset Turnover n/a n/a n/a n/a n/a n/a n/a
Interest Coverage -300.65K -671.17 -84 -5.2 -112.69 n/a n/a
Return on Equity (ROE) 156.07 -3.41 -0.52 -0.4 -0.66 1.89 0.02
Return on Assets (ROA) -3.79 -1.97 -0.32 -0.22 -0.49 -9.93 0.00
Return on Capital (ROIC) -68.46 -1.28 -0.36 -0.17 -0.49 1.14 -0.00
Dividend Yield n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a n/a

Create Price Alert on ATNFW

Your price alert will notify you when the stock price is above 0.01.

Add to Watchlist